Phase II trial of Pemetrexed for elderly advanced non-squamous non-small cell lung cancer
Not Applicable
- Conditions
- non-sq NSCLC
- Registration Number
- JPRN-UMIN000002452
- Lead Sponsor
- Kyoto Thoracic Oncology Research Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
1)active concomitant malignancy 2)pregnant or lactating woman 3)psychiatry disease 4)interstitial pneumoia/active lung fibrosis on chest x-ray 5)symptomatic brain metastasis 6)massive or uncontrolable pleural effusion 7)uncontrolable diabetes mellitus 8)uncontrolable hypertension 9)unstable angina or myocardial infarction within 6 months 10)history of severe drug allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rate
- Secondary Outcome Measures
Name Time Method 1-year survival, overall survival, progression-free survival, safety